Michael Tometsko
Medical · Pittsburgh, PANPI 1902954605
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,725 of the $15,976 with a category attached, or 67.1%. TG Therapeutics, Inc. accounts for 60.2% of it on its own, with 34 other manufacturers making up the rest. 2025 is the largest year on record at $10,121, 5.6 times the $1,800 reported in 2021. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $69.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TG Therapeutics, Inc.$10K
- Genentech USA, Inc.$2K
- AbbVie$666
- Eisai Inc.$623
- Abbott$398
- Lundbeck LLC$225
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$10,72567%
- Travel & lodging$690%
- Food & beverage$5,18232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TG Therapeutics, Inc. | 30 | $9,620 |
| Genentech USA, Inc. | 11 | $1,997 |
| AbbVie | 29 | $666 |
| Eisai Inc. | 29 | $623 |
| Abbott | 6 | $398 |
| Lundbeck LLC | 13 | $225 |
| Vanda Pharmaceuticals Inc. | 9 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $219 |
| Pfizer | 15 | $206 |
| Lilly USA, LLC | 8 | $189 |
| Biogen | 8 | $170 |
| Acadia Pharmaceuticals Inc | 5 | $132 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $122 |
| Bristol Myers Squibb | 6 | $107 |
| Argenx US, Inc. | 4 | $94 |
| AstraZeneca | 5 | $85 |
| Amgen | 5 | $84 |
| Relievant Medsystems, Inc. | 4 | $82 |
| UCB, Inc. | 4 | $81 |
| Novartis | 4 | $79 |
| Medtronic | 4 | $78 |
| Sanofi | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Nevro Corp. | 2 | $49 |
| Kyowa Kirin, Inc. | 2 | $43 |
| Neurocrine Biosciences, Inc. | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| CSL Behring | 1 | $36 |
| Grifols USA, LLC | 2 | $34 |
| EMD Serono, Inc. | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Boston Scientific | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,976 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dalfampridine ErDalfampridine | 11 | $4,715 |
| Lacosamide | 16 | $1,681 |
| Pregabalin | 57 | $1,027 |
| Gabapentin | 87 | $880 |
| Modafinil | 23 | $787 |
| Phenobarbital | 11 | $579 |
| Levetiracetam | 15 | $275 |
| Memantine Hcl | 16 | $215 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $208 |
| Clonazepam | 11 | $138 |
| Methylprednisolone | 13 | $86 |
| Baclofen | 23 | $85 |
| Tizanidine Hcl | 14 | $81 |
| Alprazolam | 15 | $46 |
| Quetiapine Fumarate | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other medical in Pittsburgh
- Patrick OffiPittsburgh$63K
- Haley WhitePittsburgh$34K
- Allyson Zella PraterPittsburgh$32K
- Braeden BashPittsburgh$27K
- Caroline O'NeilPittsburgh$25K
- Tori PipakPittsburgh$15K
- Juliette Bender HeinePittsburgh$15K
- Aimee HerringtonPittsburgh$14K
- Sarah AbrahamPittsburgh$14K
- Jacqueline KernaghanSpringfield$426K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.